On April 12, Ge Longhui (002173.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 806 million yuan, an increase of 13.51% over the previous year; net profit attributable to shareholders of listed companies was -34,287,700 yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was -280.26 million yuan; and basic earnings per share -0.08 yuan.
创新医疗(002173.SZ)：2023年度净亏损3428.77万元
Innovative Healthcare (002173.SZ): Net loss of 34.2877 million yuan in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.